EUR-Lex Access to European Union law
This document is an excerpt from the EUR-Lex website
Document 32023R1784
Commission Implementing Regulation (EU) 2023/1784 of 15 September 2023 amending Implementing Regulation (EU) No 686/2012 as regards the allocation to Member States, for the purposes of the renewal procedure, of the evaluation of etoxazole whose approval expires on 31 January 2028 (Text with EEA relevance)
Commission Implementing Regulation (EU) 2023/1784 of 15 September 2023 amending Implementing Regulation (EU) No 686/2012 as regards the allocation to Member States, for the purposes of the renewal procedure, of the evaluation of etoxazole whose approval expires on 31 January 2028 (Text with EEA relevance)
Commission Implementing Regulation (EU) 2023/1784 of 15 September 2023 amending Implementing Regulation (EU) No 686/2012 as regards the allocation to Member States, for the purposes of the renewal procedure, of the evaluation of etoxazole whose approval expires on 31 January 2028 (Text with EEA relevance)
C/2023/6123
OJ L 229, 18.9.2023, p. 89–90
(BG, ES, CS, DA, DE, ET, EL, EN, FR, GA, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
In force
|
18.9.2023 |
EN |
Official Journal of the European Union |
L 229/89 |
COMMISSION IMPLEMENTING REGULATION (EU) 2023/1784
of 15 September 2023
amending Implementing Regulation (EU) No 686/2012 as regards the allocation to Member States, for the purposes of the renewal procedure, of the evaluation of etoxazole whose approval expires on 31 January 2028
(Text with EEA relevance)
THE EUROPEAN COMMISSION,
Having regard to the Treaty on the Functioning of the European Union,
Having regard to Regulation (EC) No 1107/2009 of the European Parliament and of the Council of 21 October 2009 concerning the placing of plant protection products on the market and repealing Council Directives 79/117/EEC and 91/414/EEC (1), and in particular Article 19 thereof,
Whereas:
|
(1) |
Commission Implementing Regulation (EU) No 686/2012 (2) allocates the evaluation of active substances to a rapporteur Member State and to a co-rapporteur Member State for the purposes of the renewal procedure. The evaluation of active substances whose approval expires between 31 March 2025 and 27 December 2028 was allocated to a rapporteur Member State and a co-rapporteur Member State. However, that allocation has not yet taken place for the evaluation of the active substance etoxazole, whose approval expires on 31 January 2028. It is therefore appropriate to proceed with such allocation. |
|
(2) |
The allocation has been made in a way that ensures a balance between Member States as regards the distribution of the responsibilities and the work. |
|
(3) |
Implementing Regulation (EU) No 686/2012 should therefore be amended accordingly. |
|
(4) |
The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Plants, Animals, Food and Feed, |
HAS ADOPTED THIS REGULATION:
Article 1
In Part D of the Annex of Implementing Regulation (EU) No 686/2012, the following entry is inserted after the entry for ‘Cyantraniliprole’:
|
Active substance |
Rapporteur Member State |
Co-rapporteur Member State |
|
‘Etoxazole |
FR |
EL’ |
Article 2
This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.
This Regulation shall be binding in its entirety and directly applicable in all Member States.
Done at Brussels, 15 September 2023.
For the Commission
The President
Ursula VON DER LEYEN
(1) OJ L 309, 24.11.2009, p. 1.
(2) Commission Implementing Regulation (EU) No 686/2012 of 26 July 2012 allocating to Member States, for the purposes of the renewal procedure, the evaluation of the active substances whose approval expires by 31 December 2018 at the latest (OJ L 200, 27.7.2012, p. 5).